Novavax | NVAX - Market Capitalization


Novavax reported $1.3B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.52B 824M Mar/2026
Agenus USD 1.66B 1.55B Mar/2026
AstraZeneca USD 220.14B 68B Mar/2026
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
Cassava Sciences USD 83M 13M Mar/2026
Geron USD 843M 31M Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 303.66B 40.58B Mar/2026
Novavax USD 1.43B 340M Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025